Products

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. For more information, please select a product below.

SUFENTANIL SUBLINGUAL PRODUCTS
 

DSUVIA (sufentanil) sublingual tablet 30 mcg

In November of 2018, DSUVIA was approved by the U.S. Food and Drug Administration.

To learn more about DSUVIA, please visit DSUVIA.com.

In June of 2018, AcelRx received approval for DZUVEO from the European Commission for use in medically monitored settings.

Zalviso

Zalviso is a sufentanil sublingual tablet patient-controlled analgesia system in development for acute pain management in a medically supervised setting.

ARX-02

Higher-strength sufentanil sublingual tablets in development for cancer breakthrough pain in opioid-tolerant patients.

ARX-03

Combination sufentanil/triazolam sublingual tablet in development for procedural anxiety and acute pain.


PRE-FILLED SYRINGE PRODUCTS
 

PFS-01

Ephedrine as a 10mL ready to use pre-filled syringe of 3mg/mL ephedrine hydrochloride in development for treatment of hypotension during general anesthesia.

PFS-02

Phenylephrine as a 10mL ready to use pre-filled syringe of 50mg/mL phenylephrine hydrochloride in development for treatment of hypotension due to vasodilation (e.g. spinal anesthesia).


NAFAMOSTAT MESYLATE PRODUCTS
 

Niyad™

Nafamostat mesylate in development as a regional anticoagulant for injection into the extracorporeal circuit. *Final formulation qualification needed prior to Phase 3 initiation.

LTX-608

IV nafamostat mesylate in development for multiple conditions, including an anti-viral treatment for COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis.

 

AcelRx Pharmaceuticals makes no claims of safety or effectiveness about unapproved products. Unapproved products are not available for commercial use anywhere. Investigational products are limited by law to investigational use only.